Literature DB >> 9794174

Serum concentrations of organochlorine compounds and endometrial cancer risk (United States).

S R Sturgeon1, J W Brock, N Potischman, L L Needham, N Rothman, L A Brinton, R N Hoover.   

Abstract

OBJECTIVES: Endogenous and exogenous estrogens are important in the development of endometrial cancer. Several organochlorine compounds, such as o,p'-DDT, have estrogenic properties. The objective of this case-control analysis was to examine serum concentrations of organochlorine compounds and risk of endometrial cancer.
METHODS: Analyses were based on a sample of 90 endometrial cancer cases and 90 individually matched community controls from a multicenter case-control study in five geographic regions of the United States. Information on potential confounders, including menstrual and reproductive factors, cigarette smoking, diet, and weight, was obtained by interview.
RESULTS: The adjusted relative risk of endometrial cancer in the highest quartile of exposure compared with women in the lowest quartile was 0.7 (95 percent confidence interval [CI] = 0.2-2.0) for p,p'-DDE, and 0.9 for total polychlorinated biphenyls (PCBs) (CI = 0.4-2.5).
CONCLUSIONS: These findings do not support the hypothesis that organochlorine compounds are linked to the development of endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794174     DOI: 10.1023/a:1008823802393

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  12 in total

1.  Dietary lipids and endometrial cancer: the current epidemiologic evidence.

Authors:  Elisa V Bandera; Lawrence H Kushi; Dirk F Moore; Dina M Gifkins; Marjorie L McCullough
Journal:  Cancer Causes Control       Date:  2007-06-16       Impact factor: 2.506

2.  β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease.

Authors:  Jason R Richardson; Ananya Roy; Stuart L Shalat; Brian Buckley; Bozena Winnik; Marla Gearing; Allan I Levey; Stewart A Factor; Padraig O'Suilleabhain; Dwight C German
Journal:  Neurotoxicology       Date:  2011-05-17       Impact factor: 4.294

Review 3.  The Pine River statement: human health consequences of DDT use.

Authors:  Brenda Eskenazi; Jonathan Chevrier; Lisa Goldman Rosas; Henry A Anderson; Maria S Bornman; Henk Bouwman; Aimin Chen; Barbara A Cohn; Christiaan de Jager; Diane S Henshel; Felicia Leipzig; John S Leipzig; Edward C Lorenz; Suzanne M Snedeker; Darwin Stapleton
Journal:  Environ Health Perspect       Date:  2009-05-04       Impact factor: 9.031

4.  Occupational risk factors for endometrial cancer among textile workers in Shanghai, China.

Authors:  Karen J Wernli; Roberta M Ray; Dao Li Gao; E Dawn Fitzgibbons; Janice E Camp; George Astrakianakis; Noah Seixas; Wenjin Li; Anneclaire J De Roos; Ziding Feng; David B Thomas; Harvey Checkoway
Journal:  Am J Ind Med       Date:  2008-09       Impact factor: 2.214

Review 5.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

Review 6.  Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin.

Authors:  S M Snedeker
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

7.  Cancer mortality and environmental exposure to DDE in the United States.

Authors:  P Cocco; N Kazerouni; S H Zahm
Journal:  Environ Health Perspect       Date:  2000-01       Impact factor: 9.031

8.  Animal food intake and cooking methods in relation to endometrial cancer risk in Shanghai.

Authors:  W-H Xu; Q Dai; Y-B Xiang; G-M Zhao; W Zheng; Y-T Gao; Z-X Ruan; J-R Cheng; X-O Shu
Journal:  Br J Cancer       Date:  2006-10-24       Impact factor: 7.640

Review 9.  Endocrine-disrupting Chemicals: Review of Toxicological Mechanisms Using Molecular Pathway Analysis.

Authors:  Oneyeol Yang; Hye Lim Kim; Jong-Il Weon; Young Rok Seo
Journal:  J Cancer Prev       Date:  2015-03

Review 10.  Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.

Authors:  Dominik Rachoń
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.